These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 2244923)

  • 1. Chelerythrine is a potent and specific inhibitor of protein kinase C.
    Herbert JM; Augereau JM; Gleye J; Maffrand JP
    Biochem Biophys Res Commun; 1990 Nov; 172(3):993-9. PubMed ID: 2244923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential effects of protein kinase C activators and inhibitors on rat anterior pituitary hormone release.
    Thomson FJ; Johnson MS; Mitchell R; Wolbers WB; Ison AJ; MacEwan DJ
    Mol Cell Endocrinol; 1993 Aug; 94(2):223-34. PubMed ID: 8224525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angoline and chelerythrine, benzophenanthridine alkaloids that do not inhibit protein kinase C.
    Lee SK; Qing WG; Mar W; Luyengi L; Mehta RG; Kawanishi K; Fong HH; Beecher CW; Kinghorn AD; Pezzuto JM
    J Biol Chem; 1998 Jul; 273(31):19829-33. PubMed ID: 9677417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.
    Jarvis WD; Turner AJ; Povirk LF; Traylor RS; Grant S
    Cancer Res; 1994 Apr; 54(7):1707-14. PubMed ID: 7511048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verbascoside isolated from Lantana camara, an inhibitor of protein kinase C.
    Herbert JM; Maffrand JP; Taoubi K; Augereau JM; Fouraste I; Gleye J
    J Nat Prod; 1991; 54(6):1595-600. PubMed ID: 1812212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of protein kinase C and protein tyrosine kinase pathways in tumor necrosis factor-alpha-induced clustering of ovarian theca-interstitial cells.
    Zachow RJ; Terranova PF
    Mol Cell Endocrinol; 1993 Nov; 97(1-2):37-49. PubMed ID: 8143904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of protein kinase inhibitors on morphology and function of cultured bovine adrenal chromaffin cells: KN-62 inhibits secretory function by blocking stimulated Ca2+ entry.
    Maurer JA; Wenger BW; McKay DB
    J Neurochem; 1996 Jan; 66(1):105-13. PubMed ID: 8522941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations with the selective PKC inhibitor chelerythrine on human basophils.
    von Stebut E; Amon U; Herbert JM; Wolff HH
    Agents Actions; 1994 Jun; 41 Spec No():C56-7. PubMed ID: 7526660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor.
    Shemon AN; Sluyter R; Conigrave AD; Wiley JS
    Br J Pharmacol; 2004 Jul; 142(6):1015-9. PubMed ID: 15210579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that protein kinase C activities involved in regulating neurite growth are localized to distal neurites.
    Campenot RB; Draker DD; Senger DL
    J Neurochem; 1994 Sep; 63(3):868-78. PubMed ID: 7519663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases.
    Nixon JS; Wilkinson SE; Davis PD; Sedgwick AD; Wadsworth J; Westmacott D
    Agents Actions; 1991 Mar; 32(3-4):188-93. PubMed ID: 1650519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of [3H]staurosporine binding in protein kinase C-II purified from rat brain.
    Miyazaki A; Kitamura Y; Nomura Y
    Neurochem Int; 1993 May; 22(5):455-64. PubMed ID: 8485451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates.
    Ward NE; O'Brian CA
    Mol Pharmacol; 1992 Feb; 41(2):387-92. PubMed ID: 1538715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of epithelial Na+ permeability by protein kinase C is tissue specific.
    Chalfant ML; Civan JM; Peterson-Yantorno K; DiBona DR; O'Brien TG; Civan MM
    J Membr Biol; 1996 Aug; 152(3):207-15. PubMed ID: 8672082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of cytoplasmic calcium and protein kinases in the regulation of atrial natriuretic factor secretion by contraction rate and endothelin.
    McDonough PM; Stella SL; Glembotski CC
    J Biol Chem; 1994 Apr; 269(13):9466-72. PubMed ID: 7511588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C.
    Loomis CR; Bell RM
    J Biol Chem; 1988 Feb; 263(4):1682-92. PubMed ID: 3338987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of protein kinase C inhibits ATP-induced [Ca2+]i elevation in rat osteoblastic cells: selective effects on P2Y and P2U signaling pathways.
    Gallinaro BJ; Reimer WJ; Dixon SJ
    J Cell Physiol; 1995 Mar; 162(3):305-14. PubMed ID: 7860638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide (PACAP)-evoked increase in cyclic AMP production in chick cerebral cortex: lack of a role of the protein kinase C pathway.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2003; 55(2):245-50. PubMed ID: 12926554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H7-resistant protein kinase C substrates in two-dimensional gels of proestrous rat anterior pituitary gland.
    Simpson J; Johnson MS; Mitchell R
    Biochim Biophys Acta; 1993 Dec; 1220(1):69-75. PubMed ID: 8268247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate-dependent inhibition of protein kinase C by specific inhibitors.
    Junco M; Díaz-Guerra MJ; Boscá L
    FEBS Lett; 1990 Apr; 263(1):169-71. PubMed ID: 2332048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.